101 results
8-K
EX-10.1
CRVO
CervoMed Inc
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
is not disproportionately affected thereby;
changes in Laws after the date hereof, if the Company is not disproportionately affected thereby;
any epidemic, pandemic … or disease outbreak (including the COVID-19 virus) or any worsening of such epidemic, pandemic or disease outbreak or any declaration of martial law
8-K
EX-10.3
CRVO
CervoMed Inc
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
in this Agreement to the contrary, in connection with a pandemic, national emergency or other event that provides (or is expected to provide) a significant
8-K
EX-10.2
CRVO
CervoMed Inc
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
, and notwithstanding anything in this Agreement to the contrary, in connection with a pandemic, national emergency or other event that provides (or is expected
8-K
EX-10.1
CRVO
CervoMed Inc
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
to the contrary, in connection with a pandemic, national emergency or other event that provides (or is expected to provide) a significant disruption
8-K
EX-10.1
825emyfx
17 Nov 23
Entry into a Material Definitive Agreement
5:03pm
8-K/A
EX-99.1
jhv8aook7s0d6w
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.2
hytqcdl f2kg
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.3
fynn2z98n7v ztaaboxy
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
424B3
102fvnjzless6w8jb
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
s00 b8td3arswd
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
qjqntu9y3q5mchiknn
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
EX-2.1
kceqi 3urj
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-2.1
6oa1e6jyfsx9
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
DEFA14A
9im9dv c4u4zzec
16 Dec 22
Additional proxy soliciting materials
5:16pm
8-K
EX-99.1
6yy7a1l61rw0nnwfkor8
16 Dec 22
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
5:10pm